248 bytes added
, 15:56, 18 July 2022
* Renal excretion. Acts on COX 1/2. Inhibits renal production of prostaglandins.
* Safe for short term use in patients with stage 1-2 CKD. Risk of causing AKI is same as in general population. No evidence that it will increase risk of progression.